Nicholas Grund Akebia Therapeutics, Inc. (AKBA) insider trading activity
Nicholas Grund is Chief Commercial Officer of Akebia Therapeutics, Inc.. Currently has a direct ownership of 303,300 shares of AKBA, which is worth approximately $582,336. The most recent transaction as insider was on Jan 31, 2024, when has been sold 303,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
303K
0%
3M change
n/a
12M change
Total Value Held
$582,336
NG
Nicholas Grund
Chief Commercial Officer
Cambridge, MA